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Abstract
Tuberculosis is one of the leading causes of mortality throughout the world. Mycobacterium
tuberculosis, the causative agent of human tuberculosis, has developed several strategies involving
proteins and other compounds known collectively as virulence factors to subvert human host
defences and invade the human host. The Mce proteins are among these virulence-related proteins
and are encoded by the mce1, mce2, mce3 and mce4 operons in the genome of M. tuberculosis. It
has been proposed that these operons encode ABC-like lipid transporters; however, the nature of
their substrates has only been revealed in the case of the Mce4 proteins. Here we found that the
knockout of the mce1 operon alters the lipid profile of M. tuberculosis H37Rv and the uptake of
palmitic acid. Thin layer chromatography and liquid chromatography-mass spectrometry analysis
showed that the mce1 mutant accumulates more mycolic acids than the wild type and
complemented strains. Interestingly, this accumulation of mycolic acid is exacerbated when
bacteria are cultured in the presence of palmitic acid or arachidonic acid. These results suggest
that the mce1 operon may serve as a mycolic acid re-importer.
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Introduction
Tuberculosis is still one of the leading causes of mortality throughout the world. The HIV/
AIDS pandemic, the deterioration of public health systems in developing countries and the
emergence of multidrug-resistant forms of tuberculosis have further contributed to this
situation. Mycobacterium tuberculosis, the causative agent of tuberculosis, achieves
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infection by strategies involving the uptake and replication of the bacterium in host
macrophages and the weakening or modulation of the host immune response [1]. The
genome of M. tuberculosis contains four mce operons (mce1–4) with a similar arrangement
within the operon [2]. These operons each comprise eight genes whose organization follows
a similar pattern: two yrbE genes (A and B) are followed by six mce genes (A, B, C, D, E
and F). The proteins encoded by these operons are homologous to ATP-binding cassette
transporters (ABC-transporters) and present the typical gene arrangement of importers in
which YrbEs are homologous to permeases and have a region within the penultimate
cytoplasmic loop that may serve as the site of interaction to ATPases, whereas Mces are
homologous to substrate-binding proteins (SBP) [3]. Several groups, including ours, have
reported the relevance of Mce proteins during the replication of M. tuberculosis in mice [4–
6]. Additionally, it has been suggested that MceA plays a role in the entry of the pathogen
into non-phagocytic cells [7].
The completion of the genome sequences of Mycobacterium avium and Mycobacterium
smegmatis indicates that these opportunistic species possess orthologs of the mce genes.
Moreover, mce operons with an identical structure have been identified in all
Mycobacterium species examined and in five other species of the genus Actinomycetales
[3]. On the basis of conserved domains, previous studies have suggested that the mce and
yrbE genes encode components of transport systems [3, 8] involved in the translocation of
lipids. In line with this, it has been demonstrated that the mce4 operon encodes a cholesterol
import system that enables M. tuberculosis to derive both carbon and energy from this host
lipid [9]. Interestingly, Kendall et al. [10] have shown that mce4 is regulated by KstR, a
TetR-type regulator, along with other genes involved in fatty acid metabolism. In addition,
we have found that mce3R, a regulator of the mce3 operon, regulates the expression of
proteins involved in lipid metabolism [11]. Evidence to date thus point to the mce operons
encoding transporters of lipids or related compounds.
The fact that multiple copies of these potential lipid transporters are present in mycobacterial
genomes is consistent with the finding that pathogenic mycobacteria switch from
carbohydrates to lipids as their main carbon and energy source inside cells. This interchange
between different sources most likely requires the activity of multiple lipid or fatty acid
import systems. This is also supported by the observation that the expression of mce3 is
down-regulated in vitro [12] and that mce1 is up-regulated inside host cells [13].
A M. tuberculosis mutant deficient in the expression of one of the mce1 genes displayed
intracellular growth defects, indicating that the Mce1 transporter is required for optimal
replication inside host cells The intracellular requirement of the Mce1 proteins is in
agreement with the fact that it is the only Mce operon conserved in the obligate pathogen
Mycobacterium leprae, in spite of its genome reduction. mce1 is also the most conserved of
all mce operons across the Mycobacterium genus with orthologs in both slow and fast-
growing species including Mycobacterium smegmatis. The role of mce1 in M. tuberculosis
virulence is, however, still controversial. Surprisingly, a M. tuberculosis mce1 mutant was
found to be hypervirulent when administered intravenously or intraperitoneally, whereas it
displayed an attenuated phenotype when administered intratracheally [5, 6]. Therefore,
despite recent advances in deciphering the functions of Mce proteins as a whole, the precise
substrate transported by the Mce1 proteins and the contribution of this transporter to
intracellular growth are still poorly understood. Gaining insight into the function of this
transporter would be key to the understanding of its contribution to the adaptation of M.
tuberculosis to the host environment. In this work, we investigated the role of the Mce1
proteins in the import of fatty acids, particularly palmitic acid, and the effect of a deficiency
in these proteins on the lipid composition of M. tuberculosis.
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Bacterial strains, media and growth conditions
All cloning steps were performed in Escherichia coli DH5α grown either in Luria-Bertani
(LB) broth or on LB agar at 37°C.
M. tuberculosis and Mycobacterium smegmatis mc2155 were grown in Middlebrook
medium supplemented with albumin 0.5%, dextrose 0.4%, glycerol 0.5% (7H9-ADG) or
Middlebrook 7H11 supplemented with albumin, dextrose and glycerol (7H10-ADG). For
growth on glycerol, Sauton’s minimal medium (0.5 g/liter K2HPO40.5 g/liter MgSO4 .
7H2O, 2 g/liter citric acid, 4 g/liter L-asparagine, 0.05 g/liter ferric ammonium citrate, pH
6.9) supplemented with glycerol 0.5% was used. For growth on fatty acids as carbon source,
modified Sauton’s medium with low asparagine (0.4 g/liter) was supplemented with 0.5%
fatty acid free albumin (Sigma-Aldrich Co.) and 30 µM palmitic acid or 50 µM arachidonic
acid. When required, 50 µg/ml hygromycin, 20 µg/ml kanamycin, Tween 80 0.05% or
0.025% (vol/vol) tyloxapol were added to the medium.
Mycobacterium electrocompetent cells were prepared as described by Wards and Collins
[14].
Complementation of the mce1 mutant
The M. tuberculosis Δmce1 mutant was constructed by insertion of a hygromycin cassette
within the yrbE1B gene [5]. The mutation causes a polar effect abolishing the transcription
downstream genes. Specifically, RT-qPCR analyses showed that the mutation reduces 52
folds (p<0.05) the transcription of mce1B, while the transcription of the gene masA, which is
located downstream of mce1F, was equivalent in the mutant and in the wild type strain (fold
change 1.2, p<0.05). Complementation of the Δmce1 mutant was carried out with the entire
mce1 operon encompassing yrbE1A-mce1F. The entire mce1 operon was amplified from M.
tuberculosis H37Rv genomic DNA as two separate fragments. The mce1 upstream fragment
was amplified using the primers: upNcomce1C:
5′CCATGGTCTGCATCAGCTGGTTTCAC3′ and dwNcomce1C:
5′CCATGGTCGATCTCGAGCACTTTCCT3′. The primers carry an NcoI restriction site
(underlined). The resulting 4657 bp-PCR product carries an internal HindIII site. The mce1
downstream fragment was amplified using the following primers: upHindIIImce1C:
5′AAGCTTTACCAGTGTTCCCATGCTAT3′ and dwHindIIImce1C:
5′AAGCTTCCTTCACCTCCGTAGACGAC3′, both carrying a HindIII restriction site
(underlined). The 4657 bp-upstream fragment was cloned into the NcoI site in the
integrative pYUB178 vector, giving rise to the pYUB178::mce1up recombinant vector. The
5806 bp-downstream DNA fragment was then cloned into the internal HindIII site of
pYUB178::mce1up, giving rise to pMtmce1, the vector carrying the entire mce1 operon
used in complementation studies. The complemented mutant strains were selected on
kanamycin-containing medium. The presence of pMtmce1 in the complemented mutant
strain was verified by PCR.
Fatty acid import assay
M. tuberculosis strains were grown in Middlebrook 7H9-ADGT at 37°C until exponential
phase. Cells were washed and diluted to ~ OD600nm of 0.6–0.8 in 7H9-ADGT or Sauton low
asparagine medium supplemented with tyloxapol (minimal medium). Heat-killed cells were
used as a negative control in order to estimate the amount of radioactivity unspecifically
adsorbed to the cells. Lipid uptake experiments were performed as described by Pandey and
Sassetti [9] with 0.02 µCi/ml [14C(U)]-palmitic acid. The bacteria were incubated at 37°C
and 1-ml culture samples were taken at different time points. Cells were collected on a 0.4-
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µm Millipore filter and radioactivity counted using a 1450 Microbeta TriLux Liquid
Scintillation and Luminescence Counter (Perkin Elmer).
Lipid analysis
Total lipids from bacterial cells and culture filtrates were extracted following procedures
described earlier [16] and analyzed by TLC on silica gel 60F254 loading the same lipid
quantities per lane (300 µgr). TLCs were developed using chloroform:methanol:water
(90:10:1) or (60:30:6); η-hexane:ethyl acetate (95:5 v/v) (thrice) and revealed by spraying
with a CuSO4-phosphoric acid solution and heating.
Fatty acid and mycolic acid methyl esters (FAMES and MAMEs, respectively) were derived
from culture filtrate and extractable lipids and from cells as described by Stadthagen et al.
2005. FAMEs and MAMEs were developed three times into n-hexane:ethyl acetate (95:5 v/
v).
Liquid chromatography-mass spectrometry (LC-MS) analysis
Total lipids from M. tuberculosis H37Rv and the Δmce1 mutant grown on minimal Sauton
medium supplemented with palmitic acid as the carbon source were analysed by LC/MS as
described by Sartain et al. [17]. A high resolution Agilent 6220 TOF mass spectrometer
interfaced to a LC was used. Data files were analyzed with Agilent’s Mass hunter
workstation software (Version B.02.00, build 2.0.197.0) to identify compounds using
‘molecular feature extractor’. The Agilent mass profiler program was used to compare lipids
and mycolic acids present in the sample. Most compounds were identified using the lipid
database developed by [17]. Compounds of interest were semi-quantified by comparing their
relative abundance in the samples.
qRT-PCR
qRT-PCR reactions were performed as described by Santangelo et al [11] and Blanco et al
[18]. DNA-free RNA (1µg) was extracted from mid-exponential cultures grown in 7H9-
ADCT. The primers used are listed in the Supplementary data 1. Relative quantification was
performed by using sigA as a reference and subsequent analysis for statistical significance
was as described by Blanco et al [18].
Protein expression and immunoblot analysis
The yrbE1B, mce1A, mce1B, mce1C and mce1E genes from the mce1 operon were amplified
individually from M. tuberculosis H37Rv genomic DNA using the sets of primers listed in
Supplementary data 1. The PCR fragments were then cloned into the expression vector
pML2031 (kindly provided by Dr. M. Niederweis). pML2031 allows for the nitrile-
inducible expression of genes and production of C-terminal-fused hemagglutinin (HA)-
proteins. Recombinant vectors were electroporated into M. smegmatis mc2155. Strains were
grown on 50 ml of Hyg-containing LB until exponential phase, and the expression was then
induced by adding 500 µM isovalernitrile over night. Cells were collected, disrupted by
using a bead beater and centrifuged at 6,000g for 10 min. The supernatants were centrifuged
at 23,000g for 30 min. The pellets enriched in cell wall proteins were resuspended in 50 µl
of saline phosphate buffer (PBS) and supernatants were centrifuged at 100,000g for 2hs30
min. The pellets enriched in cell membrane proteins were resuspended in 50 µl of PBS. The
supernatants containing cytoplasmic proteins were precipitated with 10% trichloroacetic
acid, washed twice with cold acetone and resuspended in 50 µl of PBS. The protein extract
were resolved in a sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
and electroblotted onto nitrocellulose membranes (Hybond ECL 0.45µm GE Healthcare).
The localization of the YrbE1 and Mce1 proteins was analysed by Western blot using a
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monoclonal anti-HA (Sigma-Aldrich, H9658) primary antibody diluted 1:5,000; and an anti-
IgG mouse peroxidase-tagged (Sigma-Aldrich, A9044) secondary antibody diluted 1:10,000.
Immune complexes were visualized using a BCIP/NTP solution (Promega).
Results
Mutating the mce1 operon affects the uptake of palmitic acid by M. tuberculosis
To investigate the involvement of Mce1 proteins in the transport of fatty acids, we
comparatively analysed the incorporation of radiolabelled palmitic acid by the wild type,
mutant and complemented mutant strains. Figure 1A shows that the uptake of palmitic acid
was less pronounced in the mutant strain than in the wild type and complemented mutant
strains with significant differences at 2 and 4 hs (p<0.05). Importantly, M. tuberculosis mce3
mutant showed equivalent incorporation of palmitic acid to that of the wild type strain,
indicating that the observed deficiencies in the uptake of palmitic acid is specific to the mce1
mutation (Supplementary data 2).
In order to test if the Mce1 transporter is essential for the uptake of palmitic acid, we
evaluated the growth of a M. tuberculosis Δmce1 mutant in the presence of this fatty acid as
the unique carbon source. The Δmce1 mutant showed no significant alterations of growth
under this condition (Figure 1B). This result may indicate either that the palmitic acid uptake
rate in the mutant is sufficient to sustain normal growth or that other mechanisms are
triggered for the uptake of this fatty acid. A repeat palmitic acid uptake experiment in a
medium containing nanomolar concentrations of radiolabeled palmitic acid as the sole
carbon source indicated a significantly less pronounced uptake of palmitic acid in the mutant
strain compared to the wild type and complemented mutant strains at early time points, then,
levels reached a plateau for all strains (Figure 1C), likely, because all radiolabeled palmitic
acid was incorporated by cells after 60 min. As expected, M. tuberculosis incorporates more
radiolabeled palmitic acid in this limited carbon source condition than in a carbon rich
condition (Figure 1C).
The lipid profile of the mce1 mutant is altered in the presence of palmitic acid as a carbon
source
We next investigated the impact of the deletion of the mce1 operon on the lipid composition
of M. tuberculosis. When palmitic acid was used as the carbon source, the mutant strain
consistently accumulated a putative lipid compounds that were restored to wild type levels
in the complemented mutant strain (see LI in Figure 2). These phenotypes were reproducible
throughout five independent experiments. Similarly, when bacteria were grown in glucose
+glycerol medium, the LI content in the mce1 mutant showed an increase comparing to the
wild type strain (Supplementary data 3A). However, quantification of LI band intensities
indicates that in the fatty acid supplemented medium the differences in LI content between
the mce1 mutant and the wild type strain were higher than in rich medium: The average
percentages for the LI band intensity in the mutant strain relative to the wild type strain
were: 2.85 ± 1.5 in palmitic acid medium and 1.19 ± 0.2 in glucose+glycerol medium.
Preparation and TLC analysis of fatty acid methyl esters (FAMEs) and mycolic acid methyl
esters (MAMEs) from the cellular extractable lipids pointed to a increase in the mycolic acid
content of the Δmce1 mutant compared to the wild type and complemented mutant strains
(Figure 3C and Supplementary data 3B). This observation was confirmed by LC-MS
analysis of the cellular extractable lipids from the wild type and mutant strains (Figure 3A).
Mass spectra clearly showed an increase in the peaks (~ 5 folds) eluting between 22 and 24
min matching with free alpha, methoxy and ketomycolates in the Δmce1 mutant (Figure 3B).
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It has been reported previously that the growth of a mutant in fadD5 (a member of the mce1
operon) of M. tuberculosis is slightly affected when bacteria are cultured in mycolic acid as
sole carbon source, suggesting that mycolic acids may serve as substrates for Mce1 [19]. We
thus analysed by TLC the mycolic acid content of the culture filtrates from the WT, mutant
and complemented mutant strains. TLC analysis of the MAMEs prepared from culture
filtrate lipids indicated that this content was increased in the mce1 mutant compared to the
wild type and complemented mutant strains (Figure 3D).
The lipid profile of the mce1 mutant is altered in the presence of arachidonic acid as a
carbon source
A search on the TBdatabase (http://www.tbdb.org) showed that the expression of some mce1
genes is altered in the presence of either palmitic or arachidonic acids or both. For this
reason, we also analyzed the lipid profile of the mutant, wild type and complemented strains
in minimal medium supplemented with 50 µM arachidonic acid. After two months of
culturing all M. tuberculosis strains reached an optical density (OD600nm) lower than 0.2,
indicating that M. tuberculosis grows poorly on arachidonic acid as carbon source (data not
shown). The lipid profile of the mutant grown under this culture condition appeared similar
to that of the bacteria grown in palmitic acid when resolved in the solvent system
chloroform: methanol: water 90:10:1 (Figure 4A and B and 2A and B), showing
accumulation of the LI compound in the cellular extractable and supernatant fractions.
Remarkably, in the culture supernatant lipid fraction, the mycolic acid content was increased
in the Δmce1 mutant as compared to the wild type and complemented strains (Figure 3F).
However, in the cellular extractable lipid fraction this mycolic acid accumulation was not as
obvious as in culture supernatant lipid fraction of the mutant strain (Figure 3E).
Surprisingly, the complemented mutant strain showed a significant decrease in mycolic acid
content compared to both the wild type and complemented mutant strains in arachidonic
culture condition. Although the reason of this diminished content of mycolic acid in the
complemented mutant strain is not clear, we speculate that in this strain, the negative
regulation of mce1 operon exerted by the Mce1 transcriptional repressor is unbalanced due
to presence of an additional copy of mce1 promoter/regulation region (one copy is in the
wild type locus and other is in the integrative plasmid). As a consequence, more Mce1
proteins would be produced, resulting in less accumulation of mycolic acids.
In order to determine whether or not the LI compounds were free mycolic acids, cellular
extractable lipids from bacteria grown in different carbon sources were solved in preparative
TLCs and the materials migrating at LI position were purified from the silica and treated as
they were mycolic acids. The lipid profile of all LI fractions showed a typical mycolic acid
pattern (Figure 5).
Altogether these results indicate that the Mce1 proteins are important for the homeostasis of
free mycolic acid of M. tuberculosis.
Most of the Mce1 proteins localize in the cell wall
Based on bioinformatics predictions, Casali et al. [3] proposed that the YrbE1AB and
Mce1A-F proteins constitute the permeases and SBP of an ABC transporter, respectively,
with the protein Mkl (Rv0655) being the ATPase providing the energy for metabolite
translocation. In addition, Song et al. [20] proposed that the mceA-F genes of M.
tuberculosis encode outer membrane proteins (OMPs) which form an outer membrane
complex. Based on these predictions, it has been hypothesized that the Mce proteins
localized to the surface and/or into the cell wall. However, until now, only Mce1A has been
shown to localize at the surface of the bacterium [21]. In order to gain insight into the
localization of the proteins encoded in mce1 operon, we expressed the proteins YrbE1B,
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Mce1A, Mce1B, Mce1C and Mce1E of M. tuberculosis as HA-fusion under an inducible
promoter in M. smegmatis. Previous attempts to express mce1 genes under a constitutive
promoter in M. smegmatis or M. tuberculosis were unsuccessful (data not shown). Western
blot analysis using anti-HA antibodies detected recombinant YrbE1B-HA exclusively in
membrane-enriched fraction. Mce1A-HA, Mce1B-HA and Mce1E-HA proteins were
present in the cell wall-enriched fractions but less intense bands were also detected in the
membrane-enriched fractions (Figure 6). Similarly, an analysis of cytoplasm, cell membrane
and cell wall proteome profiles of M. tuberculosis have identified Mce1A in cell membrane
fraction [22]. Although the whole Mce1C-HA protein (53.8 KDa) is predominant in the cell
wall-enriched fraction, very intensive low molecular weight bands, likely corresponding to
degraded forms of the proteins, were detected in cell membrane fraction (Supplementary
data 4A). Therefore, from these results it is not possible to determine the distribution of
Mce1C in the cell envelope compartments.
Taken together, these results are consistent with the role proposed for Mce as a transporter
localized in the mycobacterial cell envelope.
Discussion
Here we found that the mutation of the mce1 operon in M. tuberculosis produced an increase
in the amount of mycolic acids, mainly in the culture supernatant lipid fraction, together
with the accumulation of putative lipid. Remarkably, this alteration in the mutant lipid
profile was only substantial when the carbon source in the culture medium was palmitic or
arachidonic acids. In addition, the mce1 mutation in M. tuberculosis significantly affected
the uptake of palmitic acid. The mutant’s phenotypes suggest two possible scenarios.
In one scenario, the Mce1 system directly participates in the transport of palmitic acid. This
role is consistent with the reduced uptake of this specific fatty acid in the mutant strain.
In the second-scenario, Mce1 system is involved in the lipid remodelling that occurs when
Mycobacterium is cultivated in the presence of different carbon sources. This Mce1-driven
lipid remodelling is more intensive in limited carbon sources or in the presence of fatty
acids, such as palmitic or arachidonic acids. This is consistent with the quantitative
alterations in the lipid profile of the mutant strain in palmitic and arachidonic acids media.
This last scenario is supported by the finding that mycobacteria and other microbes recycle
cell wall components as a strategy to preserve scarce resources [23]. Importantly, during the
preparation of this paper, Cantrell et al. reported that free mycolic acids accumulate in a
mce1 mutant strain of M. tuberculosis [24], sustaining the results of this study. However,
opposite to the Cantrell′s observations we did not detect major alterations in the free mycolic
acid accumulation among strains when bacteria were grown in glycerol as carbon source.
Differences in the glycerol-containing culture media and methodologies used in both studies
may explain these dissimilar results. Kalscheuer et al. have found that the LpqY-SugA-
SugB-SugC ATP-binding cassette transporter is a recycling system mediating the retrograde
transport of released trehalose in M. tuberculosis and M. smegmatis [25]. These authors
proposed a model in which the trehalose moieties released from trehalose monomycolate by
mycobacteria upon mycolic acid transfer to cell envelope acceptors are recycled by the cells
to continue serving as a carrier of mycolic acids to the periplasm or to serve as a carbon
source during growth in nutrient-limited microenvironments in vivo. In addition, Dunphy et
al. have demonstrated that mycolic acid can be used by M. tuberculosis as a carbon source
[19]. In connection with that, Dunphy et al. study showed that a M. tuberculosis mutant in
the putative fatty acid binding site of fadD5, a gene co-transcribed with mce1 genes, showed
decreased growth in minimal medium containing mycolic acid, thus suggesting that FadD5
participates in mycolic acid degradation. Dunphy’s study has also shown that a M.
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tuberculosis mce1 operon mutant (which expresses intact FadD5) was able to grow normally
in mycolic acid [19], suggesting that in this growth condition others transporters participate
in mycolic acid recycling. In this regard, it is important to note that we mainly detected
mycolic acid accumulation when the mutant was grown in palmitic or arachidonic acids, a
condition different from that used by Dunphy et al. [19]. In this scenario, we hypothesize
that, similarly to trehalose recycling, free mycolic acids and other cell wall lipid compounds
are recycled to be used as substrates of lipid biosynthesis and/or as carbon sources in
starvation conditions. This is in agreement with the concept that pathogenic mycobacteria
switch their metabolism from carbohydrate to lipid pathways during their intracellular life.
In this study we found that the Mce proteins localize mainly in the cell wall, which is
consistent with a role as substrate binding proteins of importer systems. We also
demonstrated for the first time that the lack of Mce1 proteins affects the cell wall lipid
structure, impairing the fatty acid uptake. These results together with the finding that
mycolic acids accumulated extracellularly in the Δmce1 mutant suggest that Mce1 may
serve as a mycolic acid re-importer in limited conditions of growth.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Palmitic acid uptake in M. tuberculosis strains
A) Palmitic acid uptake of M. tuberculosis H37Rv (H37Rv), the Δmce1 mutant (Δmce1) and
the complemented mutant strain (Comp). The cells were grown in a rich medium (7H9-
ADGT) until exponential growth phase and diluted at OD600nm 0.6. The uptake was started
by adding rich medium containing 0.02 µCi/ml [14C]-palmitic acid. Aliquots of 1ml were
taken at different time points and the amount of radioactivity associated to the cells was
counted and expressed relative to the OD600nm of the culture. B) Growth of M. tuberculosis
H37Rv (H37Rv) and the Δmce1 mutant (Δmce1) in minimal medium with tyloxapol and
supplemented palmitic acid as carbon source. C) Palmitic acid uptake of bacteria in minimal
medium. The wild type (H37Rv, mutant (Δmce1) and complemented mutant (Comp) strains
were grown in rich medium (7H9-ADGT) until exponential growth phase then were washed
and suspended at OD600nm 0.6 in low asparagine medium containing tyloxapol and 0.02
µCi/ml [14C]-palmitic acid. Aliquots were taken and counting. The cells exposed to 80°C
for 1 hour (killed) were used as a measure of the background radioactivity bound to the
cells. Statistically significant differences were observed between the wild type (H37Rv) and
mutant (Δmce1) strains where (*) p< 0.05 and (***) p<0.001. The graph 1A shows a
representative experiment of two experiments performed in duplicate while the graph 1C
shows a representative experiment of four experiments performed in duplicate.
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Figure 2. The lipid profile of the Δmce1 mutant is altered in response to palmitic acid as carbon
source
Total lipids were extracted from M. tuberculosis H37Rv (H37), the Δmce1 mutant (Δmce1)
and the complemented mutant strain (Comp) grown in minimal medium supplemented with
palmitic acid. The lipids were developed by TLC in the solvent system
chloroform:methanol:water (90:10:1) and revealed with CuSO4 and heating. The arrows
indicate the LI increased lipids in the Δmce1 mutant. A) Cellular extractable lipids and B)
Lipids from the culture supernatant. These lipid patterns were repeated in five independent
experiments.
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Figure 3. The mycolic acids are increased in the Δmce1 mutant
A) Chromatogram of liquid chromatography-mass spectrometry (LC-MS) of cellular lipids
from M. tuberculosis strains showed an increased peaks in the Δmce1 mutant (top) in
relation with the wild type H37Rv (bottom). Peaks between 9 and 16 minutes are
cardiolipids. B) Mass spectra of grey area showed in A. The peaks indicated with arrows
were identified by mass spectrometry as to free mycolic acids (not shown): 1136=C-78
alpha; 1224=C-83 methoxy 1236=C-84 keto 1252= C-84 methoxy. C, D, E, F) FAMEs and
MAMEs prepared from cellular extractable (C, E) and lipids from supernatant (D, F) from
M. tuberculosis H37Rv (H37), the Δmce1 mutant (Δmce1) and complemented mutant strain
(Comp) cultured in minimal medium supplemented with palmitic (C, D) or arachidonic
acids (E, F) as carbon sources. The same quantities of samples were loaded per lane and the
TLC plate was developed using n-hexane:ethyl acetate (95:5) (thrice) as the solvent system.
Compounds were revealed using cupric sulfate. α, alpha-mycolates; M, methoxy-mycolates,
K, keto-mycolates. The TLCs of this figure represent the results of three experiments.
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Figure 4. The lipid profile of the Δmce1 mutant is altered in response to arachidonic acid as
carbon source
Cellular extractable (A) and supernatant (B) lipids from M. tuberculosis H37Rv (H37), the
Δmce1 mutant (Δmce1) and complemented mutant strain (Comp) cultured in minimal
medium supplemented with arachidonic acid. The lipids were developed by TLC from
bottom to top using chloroform:methanol:water in the following proportions: 90:10:1. TLCs
were stained with CuSO4. The arrows indicate the increased lipid LI in the Δmce1 mutant.
These lipid patterns were repeated in three independent experiments.
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Figure 5. LI lipids are free mycolic acids
Compounds migrating at LI positions indicated in Figures 2A, 4A and Supplementary data
3A were eluted from the silica gel plate and processed as they were MAMEs/FAMEs. LI
fractions obtained from Δmce1 mutant cultured in arachidonic acid (AA), palmitic acid (PA)
or glucose+glycerol (GG) were developed by TLC in the solvent system nhexane: ethyl
acetate (95:5) (thrice) and revealed with CuSO4 and heating. FAMEs/MAMEs prepared
from whole M. tuberculosis cells (W) were run in parallel.
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Figure 6. Subcellular localization of the Mce1 proteins
YrbE1B, Mce1A, Mce1B, Mce1C and Mce1E were expressed as C-ter hemaglutinine (HA)
fusion proteins. The mce genes were cloned into the pML2031 vector, the proteins were
expressed by the added of 500 µM isovalernitrilo in M. smegmatis. The proteins secreted to
the supernatant (CS), those of the cell wall-enriched fraction (CW), membranes-enriched
fraction (CM) and cytoplasmic soluble proteins (S) were resolved in a 12% SDS-PAGE and
detected by western blotting using an anti-HA and anti-IgG conjugated with phosphatase as
primary and secondary antibodies, respectively. Molecular weights of recombinant proteins
(kDa) are indicated on the left.
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